Follow
Michelle Gittelman
Michelle Gittelman
Rutgers Business School
Verified email at business.rutgers.edu
Title
Cited by
Cited by
Year
Patent citations as a measure of knowledge flows: The influence of examiner citations
J Alcacer, M Gittelman
The review of economics and statistics 88 (4), 774-779, 2006
9342006
Does good science lead to valuable knowledge? Biotechnology firms and the evolutionary logic of citation patterns
M Gittelman, B Kogut
Management Science 49 (4), 366-382, 2003
8892003
Applicant and examiner citations in US patents: An overview and analysis
J Alcácer, M Gittelman, B Sampat
Research Policy 38 (2), 415-427, 2009
4612009
Does geography matter for science-based firms? Epistemic communities and the geography of research and patenting in biotechnology
M Gittelman
Organization science 18 (4), 724-741, 2007
3342007
National institutions, public–private knowledge flows, and innovation performance: A comparative study of the biotechnology industry in the US and France
M Gittelman
Research Policy 35 (7), 1052-1068, 2006
1612006
How do I know what you know? Patent examiners and the generation of patent citations
J Alcacer, M Gittelman
Patent Examiners and the Generation of Patent Citations (August 2004), 2004
1532004
A note on the value of patents as indicators of innovation: Implications for management research
M Gittelman
Academy of Management Perspectives 22 (3), 21-27, 2008
1432008
The revolution re-visited: Clinical and genetics research paradigms and the productivity paradox in drug discovery
M Gittelman
Research Policy 45 (8), 1570-1585, 2016
1022016
Research paradigms and useful inventions in medicine: Patents and licensing by teams of clinical and basic scientists in Academic Medical Centers
A Ali, M Gittelman
Research Policy 45 (8), 1499-1511, 2016
492016
Japanese multinationals in Europe and the United States: some comparisons and contrasts
M Gittelman, JH Dunning
Multinationals in the new Europe and global trade, 237-268, 1992
401992
Question‐based innovations in strategy research methods
A Arora, M Gittelman, S Kaplan, J Lynch, W Mitchell, N Siggelkow
Strategic Management Journal 37 (1), 3-9, 2016
362016
How do I know what you know
J Alcacer, M Gittelman
Patent examiners and the generation of patent citations, 2004
362004
Mapping national knowledge networks: Scientists, firms, and institutions in biotechnology in the United States and France
M Gittelman
University of Pennsylvania, 2000
312000
What makes research socially useful? Complementarities between in-house research and firm-university collaboration in biotechnology
M Gittelman
Revue d'économie industrielle 110 (1), 57-73, 2005
292005
The performance and structure of Japanese affiliates in the European Community
M Gittelman, E Graham
Does ownership matter, 127-158, 1994
181994
Comment: The value of European patents
M Gittelman
European Management Review 5 (2), 85-89, 2008
162008
Are licensing markets local? An analysis of the geography of vertical licensing agreements in bio-pharmaceuticals
J Alcacer, J Cantwell, M Gittelman
HBS Working paper, 2009
142009
Scientific maps and innovation: Impact of the human genome on drug discovery
S Jayaraj, M Gittelman
DRUID Society Conference, 1-56, 2018
132018
Transnational corporations in Europe 1992: implications for developing countries
M GITTELMAN
The CTC Reporter 29, 35-42, 1990
121990
Japanese multinationals in Europe and the United States: some comparisons and contrasts
JH Dunning
University of Reading, Department of Economics, 1991
111991
The system can't perform the operation now. Try again later.
Articles 1–20